Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS)
CNY 9.07
(3.66%)
CNY 9.07
(3.66%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 221.84 Million | 120.56 Million | 173.9 Million | 138.47 Million | 87.72 Million | 11.5 Million |
| Net Income | 253.9 Million | 235.37 Million | 145.93 Million | 86.83 Million | 56.38 Million | 43.86 Million |
| Depreciation & Amortization | 40.59 Million | 34.47 Million | 30.02 Million | 25.42 Million | 22.73 Million | 20.7 Million |
| Deferred income taxes | -3.57 Million | 10.11 Million | 245.1 Thousand | -1.31 Million | -935.27 Thousand | 146.92 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -70.96 Million | -114.96 Million | -7.28 Million | -5.76 Million | 4.46 Million | -39.2 Million |
| Other non-cash items | 186.09 Million | -34.32 Million | 5.23 Million | 31.97 Million | 4.15 Million | -13.85 Million |
| Investing Cash Flow | -175.47 Million | -177.84 Million | -432.3 Million | -105.44 Million | -2.21 Million | -36.67 Million |
| Investments in PPE | -163.47 Million | -271.91 Million | -310.85 Million | -92.95 Million | -49.62 Million | -55.05 Million |
| Acquisitions | 191.41 Thousand | 186.78 Thousand | 211.22 Thousand | 12.46 Thousand | 37.72 Thousand | 71.9 Thousand |
| Investment purchases | -18.92 Million | -17.5 Million | -10 Million | -13.07 Million | -150 Million | -225 Million |
| Sales/Maturities of investments | 6.73 Million | 619.48 Million | 516.75 Million | 115.36 Million | 195.83 Million | 686.44 Thousand |
| Other Investing Activities | 5.8 Million | -508.1 Million | -628.42 Million | -114.78 Million | 1.54 Million | 17.69 Million |
| Financing Cash Flow | 469.92 Million | 94.91 Million | 37.03 Million | 390.19 Million | -38.45 Million | 57.82 Million |
| Debt repayment | -58.3 Million | -103.15 Million | -151 Million | -84.9 Million | -144 Million | -86.95 Million |
| Dividends payments | -47.44 Million | -29.27 Million | -17.94 Million | -12 Million | -8.8 Million | -14.17 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 469.07 Million | 235.74 Million | 208 Million | 488.49 Million | 116.9 Million | 158.94 Million |
| Accounts receivables | 34.45 Million | -69.41 Million | -101.89 Million | 24.44 Million | -552.41 Thousand | 8.83 Million |
| Accounts payables | -26.03 Million | 97.46 Million | 151.34 Million | -22.37 Million | 72.66 Million | -42.72 Million |
| Inventory | -79.38 Million | -153.13 Million | -56.98 Million | -6.51 Million | -66.71 Million | -5.45 Million |
| Other working capital | -29.6 Million | 10.11 Million | 245.1 Thousand | -1.31 Million | -935.27 Thousand | -33.74 Million |
| Cash at beginning of period | 597.68 Million | 488.92 Million | 720.93 Million | 317.62 Million | 266.96 Million | 220.86 Million |
| Cash at end of period | 1.12 Billion | 563.74 Million | 488.92 Million | 720.93 Million | 317.62 Million | 266.96 Million |
| Capital Expenditure | -163.47 Million | -271.91 Million | -310.85 Million | -92.95 Million | -49.62 Million | -55.05 Million |
| Effect of forex changes on cash | 7.95 Million | 37.18 Million | -10.63 Million | -19.92 Million | 3.59 Million | 13.44 Million |
| Net cash flow / Change in cash | 526.54 Million | 74.81 Million | -232 Million | 403.3 Million | 50.66 Million | 46.1 Million |
| Free Cash Flow | 58.37 Million | -151.34 Million | -136.95 Million | 45.51 Million | 38.1 Million | -43.55 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 49.15 Million | 67.35 Million | 112.48 Million | 253.9 Million | 28.56 Million | 65.14 Million |
| Depreciation & Amortization | - | 15.59 Million | 15.59 Million | 40.59 Million | 10.57 Million | -19.6 Million |
| Deferred income taxes | - | - | - | -3.57 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | -70.96 Million | -44.92 Million | 165.9 Million |
| Other non-cash items | 7.33 Million | -39.81 Million | -85.49 Million | 186.09 Million | 10.57 Million | -241.62 Million |
| Investing Cash Flow | -43.4 Million | -32.48 Million | -21.27 Million | -175.47 Million | -65.26 Million | -43.86 Million |
| Investments in PPE | -39.96 Million | -33.67 Million | -21.27 Million | -163.47 Million | -65.46 Million | -48.2 Million |
| Acquisitions | - | - | - | 191.41 Thousand | 191.41 Thousand | - |
| Investment purchases | - | -2.24 Million | - | -18.92 Million | -922.78 Thousand | -500 Thousand |
| Sales/Maturities of investments | -3.43 Million | 3.43 Million | - | 6.73 Million | 6.73 Million | - |
| Other Investing Activities | - | 1.18 Million | - | 5.8 Million | -6.11 Million | 4.83 Million |
| Financing Cash Flow | 21.64 Million | -89.05 Million | -19.75 Million | 469.92 Million | -6.15 Million | -46.53 Million |
| Debt repayment | -100 Million | -99.9 Million | -70 Million | -58.3 Million | -10.47 Million | - |
| Dividends payments | - | -2.13 Million | -1.63 Million | -47.44 Million | -47.44 Million | -49.95 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -78.35 Million | 10.84 Million | -19.75 Million | 469.07 Million | 6.45 Million | 3.41 Million |
| Accounts receivables | - | - | - | 34.45 Million | 34.45 Million | 136.02 Million |
| Accounts payables | - | - | - | -26.03 Million | - | - |
| Inventory | - | - | - | -79.38 Million | -79.38 Million | 29.88 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 989.37 Million | 1.11 Billion | 1.12 Billion | 597.68 Million | 1.02 Billion | 1.07 Billion |
| Cash at end of period | 1.02 Billion | 989.37 Million | 1.11 Billion | 1.12 Billion | 1.12 Billion | 951.79 Million |
| Capital Expenditure | -39.96 Million | -33.67 Million | -21.27 Million | -163.47 Million | -65.46 Million | -48.2 Million |
| Effect of forex changes on cash | - | 2.62 Million | -691.99 Thousand | 7.95 Million | -3.93 Million | -4.36 Million |
| Net cash flow / Change in cash | 36.03 Million | -125.56 Million | -9.29 Million | 526.54 Million | 101.49 Million | -124.95 Million |
| Free Cash Flow | 16.52 Million | -21.72 Million | 5.7 Million | 58.37 Million | 146.09 Million | -78.38 Million |
HR-UN
BMXC
GIGA
000807
ALDVF
601878